Definitive Contract W911SR26CA003
Award Date 2/2/26
Potential Completion Date 8/1/27
Potential Value $1.4M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Palmetto Bay, FL 33176, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This is a firm fixed-price SBIR Phase I contract awarded by the Joint PEO Chemical and Biological Defense, a Defense agency, to Cygnos Biotech, LLC, a small business located in Miami, Florida. The contract, valued at $204,493.42, is for research to create a class of agnostic drugs that can assist in fighting off a broad spectrum of viral pathogens. The contract has an ultimate completion date of August 9, 2025.</p>
- This is a $1,099,949.64 firm fixed-price Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army's Research, Development and Engineering Command (RDECOM) to CFD Research Corporation, a small engineering and technology firm based in Huntsville, Alabama. The contract is for the development of a new broad-spectrum antiviral drug against viruses from the Bunyaviral family. This SBIR Phase II award builds upon prior Phase I research and will support further development of...
- The Defense Health Agency awarded a $249,956.88 Small Business Innovation Research Phase 1 contract to Firebird Biomolecular Sciences LLC for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics." The firm-fixed-price purchase order, set aside for small businesses, was awarded on October 9, 2024, with performance completion targeted for May 8, 2025. Firebird Biomolecular Sciences LLC, a small business specializing in advanced molecular diagnostics and...
- This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Joint Program Executive Office for Chemical and Biological Defense, a Department of Defense agency, to Bioo Scientific Corporation, a subsidiary of Revvity Inc. The $116,638.65 firm-fixed-price contract supports research and development work related to the SBIR program. The contract was awarded on June 14, 2016, with a completion date of June 13, 2017. As an SBIR Phase I contract, this award supports...
- The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a Small Business Innovation Research (SBIR) Phase I contract to Nano Terra, Inc., a self-certified small disadvantaged business, for research and development on a topic related to chemical/biological defense. The firm-fixed-price contract, with a potential value of $149,756.40, was awarded on October 1, 2018 and is scheduled for completion by March 31, 2019. This SBIR Phase I contract is set...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Chimerocyte, Inc., a for-profit organization. The contract, valued at $1,092,350.01, is for the development of "Iodide for the Treatment of Influenza and Other Stresses" under a Firm Fixed Price agreement. The contract has a period of performance through September 29, 2024. This SBIR Phase II award builds upon a previous SBIR Phase I...
- The Defense Health Agency awarded a $10.6 million firm fixed-price contract to Ophirex, Inc., a small business located in Corte Madera, California, under the Small Business Innovation Research (SBIR) Phase III program. The contract, awarded June 19, 2020, with an ultimate completion date of September 29, 2023, supports research and development of varespladib, a secretory phospholipase A2 (sPLA2) inhibitor designed to treat acute respiratory distress syndrome (ARDS) associated with SARS-CoV-2....
- Fabrico Technology, Inc., a minority-owned small business based in Pflugerville, Texas, has been awarded a Phase II Small Business Innovation Research (SBIR) contract valued at $1,099,418.28 by the Joint PEO Chemical and Biological Defense, a defense-focused agency under the Department of Defense. The contract, designated as a small business set-aside with firm fixed-price terms, was awarded on May 25, 2023, with an ultimate completion date of May 26, 2026. The primary objective of this research...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Air Force Research Laboratory (AFRL) to Integrated Viral Protection Solutions LLC for the development of a portable, battery-powered biodefense air protection system for use by Airmen during missions. The firm-fixed-price contract has a ceiling value of $49,999 and a completion date of May 29, 2023. As this is a Small Business set-aside contract, Integrated Viral Protection Solutions LLC is the prime contractor...
- This federal contract award, valued at $149,964.61, was made by the Joint Program Executive Office for Chemical and Biological Defense, a U.S. Department of Defense organization, to Abzyme Therapeutics LLC, a small, minority-owned, for-profit limited liability company. The contract was awarded under the Small Business Innovation Research (SBIR) program, Phase I, and is a firm-fixed-price purchase order. The contract supports research and development work by Abzyme Therapeutics related to...